CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Slides:

Advertisements

Similar presentations

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

Advertisements

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Bleeding Toes in Diabetic Neuropathy

The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes Edy Kornelius, MD, Jeng-Yuan Chiou, PhD, Yi-Sun Yang, PhD, MD,

Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients Chun-Chin Chang, MD, Yung-Tai.

Sexuality The American Journal of Medicine

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Unusual Cause of Leg Ulcerations

Characteristics of Hospitalized Patients with Atrial Fibrillation in Taiwan: A Nationwide Observation Cheng-Han Lee, MD, Ping-Yen Liu, MD, PhD, Liang-Miin.

Acute Paralysis in a Uremic Patient

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Alcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case- crossover Study Tuhina Neogi, MD, PhD, Clara Chen, MHS, Jingbo Niu,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Cardiovascular Disease and CKD: Core Curriculum 2010

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients Chun-Chin Chang, MD, Yung-Tai.

Hypertensive Disorders in Pregnancy and Subsequent Diabetes Mellitus: A Retrospective Cohort Study I-Kuan Wang, MD, I-Ju Tsai, MS, Pei-Chun Chen, PhD,

Andre J. Gauri, MD, Andrew Davis, MD, Thomas Hong, MD, Martin C

The Reply The American Journal of Medicine

TIA for the Internist The American Journal of Medicine

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

Lead Intoxication Caused by Traditional Chinese Herbal Medicine

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

When Guidelines Cause Hypertension

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Optimizing Atrial Fibrillation Management

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery Su-Kiat Chua, MD,

The Malnourished Heart: An Unusual Case of Heart Failure

The Reply The American Journal of Medicine

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

MATCH Results: Implications for the Internist

Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome Allison J. Kasmari, MD, Amy Welch, MD, MSN,

Prevalence and Risk Factors for Erectile Dysfunction in the US

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Cluster Syncope The American Journal of Medicine

To Reduce Stroke with PFO Closure, Respect the Shunt

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta- Analysis of Randomized Trials David S. Wald, MA, MRCP, MD, Anuradhani.

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

National Trends in Ambulatory Oral Anticoagulant Use

Aorta–Aorta Fistula: Another Uncommon Cause of Heart Failure

Plasma Lactescence in Acute Pancreatitis

Falls in Older Adults: Risk Assessment, Management and Prevention

Figure 8. Stroke prevention strategy in patients with AF

Toward a More Responsible News Media

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation Chen-Ying Hung, MD, Ching-Heng Lin, PhD, El-Wui Loh, PhD, Chih-Tai Ting, MD, PhD, Tsu-Juey Wu, MD, PhD The American Journal of Medicine Volume 126, Issue 2, Pages 133-140.e1 (February 2013) DOI: 10.1016/j.amjmed.2012.06.027 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Specific subgroup analysis for new-onset atrial fibrillation. CHADS2=Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Stroke or transient ischemic attack; CI=confidence interval; HR=hazard ratio. The American Journal of Medicine 2013 126, 133-140.e1DOI: (10.1016/j.amjmed.2012.06.027) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Atrial fibrillation-free survival rate according to statins use and CHADS2 score. (A) CHADS2 score of 1, (B) CHADS2 score ≥2. CHADS2=Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Stroke or transient ischemic attack. The American Journal of Medicine 2013 126, 133-140.e1DOI: (10.1016/j.amjmed.2012.06.027) Copyright © 2013 Elsevier Inc. Terms and Conditions